$VNCE Cashflow Statement | Understand Stock

$VNCE

$11.22 -$0.19 (1.67%) Close

$VNCE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 31, 2026	FY2024 12 months to Feb 1, 2025	FY2023 12 months to Feb 3, 2024	FY2022 12 months to Jan 28, 2023	FY2021 12 months to Jan 29, 2022
Operating activities
Net income (loss)
Add (deduct) items not affecting operating cash flows:
Impairment of intangible assets
Impairment of long-lived assets
Impairment of goodwill
Depreciation and amortization
Allowance for doubtful accounts
Gain on sale of intangible assets
Gain on sale of subsidiary
Loss on disposal of property and equipment
Amortization of deferred financing costs
Deferred income taxes
Share-based compensation expense
Capitalized PIK Interest due to loan with former related party
Loss on debt extinguishment
Equity in net income of equity method investment, net of distributions
Changes in assets and liabilities:
Receivables, net
Inventories
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Other assets and liabilities

Net cash provided by operating activities
Investing activities
Payments for capital expenditures
Transaction costs related to equity method investment
Proceeds from sale of intangible assets
Net cash used in investing activities
Financing activities
Proceeds from borrowings under the Revolving Credit Facilities
Repayment of borrowings under the Revolving Credit Facilities
Repayment of borrowings under the Term Loan Facilities
Proceeds from borrowings under the Term Loan Facilities
Repayment of borrowings under the Third Lien Credit Facility
Tax withholdings related to restricted stock vesting
Proceeds from stock option exercises, restricted stock vesting, and issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from issuance of common stock, net of certain fees
Financing fees
Net cash provided by (used in) financing activities

(Decrease) increase in cash, cash equivalents, and restricted cash
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Less: restricted cash at end of period
Cash and cash equivalents per balance sheet at end of period
Supplemental Disclosures of Cash Flow Information
Cash payments for interest
Cash payments for income taxes, net of refunds
Supplemental Disclosures of Non-Cash Investing and Financing Activities
Non-cash equity method investment
Deemed contribution in connection with debt extinguishment
Capital expenditures in accounts payable and accrued liabilities
Contribution from principal stockholder in accounts receivable
(Write-off)/contribution from principal stockholder in accounts receivable
Deferred financing fees in accrued liabilities

Comments